A major scientific review published in late 2025 has refined the clinical understanding of medical marijuana. While public interest remains high for various conditions, the review highlights that "Strong Scientific Evidence" is currently concentrated in three specific areas: Chronic Neuropathic Pain, Chemotherapy-Induced Nausea, and Refractory Epilepsy (notably Dravet and Lennox-Gastaut...